Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

Agentic Clinical Operations and AI Automation Systems

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

541512 - Computer Systems Design Services

Place of Performance

DC

Set-Aside

NONE

Documents

This scope was carved out of ARPA-H-SOL-26-164.

The full solicitation package (3 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Develops AI-enabled operational systems and clinical operations frameworks for prime contractors on ARPA-H projects. Automates platform-level pre-trial activities, site-activation workflows, and Master Protocol document generation using AI/LLM frameworks. Ensures compliance with Good Clinical Practice (GCP) and data integrity standards. Delivers an AI-enabled operational framework and automated document tools.

Similar Contracts

Same NAICS industry code

NAICS: 541512
New
SLED
New England Child Support Enforcement System (NECSES) Technology Evolution
Solicitation # RFI-2027-DES-01-NECSES
The New Hampshire Department of Health and Human Services is issuing Request for Information RFI-2027-DES-01-NECSES to gather market research and vendor capabilities for the technology evolution of the New England Child Support Enforcement System (NECSES). This mission-critical, federally certified application currently relies on aging Java and Oracle Forms and Reports technologies. The State seeks strategies to address technical and architectural debt to improve security, scalability, and maintainability while preserving essential business functionality, complex integrations, and federal certification. The Department is exploring various low-risk, incremental approaches, including automated code conversion, low-code platforms, and SaaS offerings, to avoid the disruption of a single large-scale replacement. Responses are due by October 16, 2026, at 12:00 PM EST and must be submitted via email to the designated point of contact, Sara Kelly. Proposed solutions must adhere to strict regulatory and technical standards, including Section 508 and WCAG 2.2 Level AA accessibility, NIST-aligned security controls, and Federal Office of Child Support Enforcement requirements. For SaaS components, the State prefers SOC 2 Type II and FedRAMP attestations. As this is an RFI for discovery and planning purposes, it is not intended to result in a contract or vendor agreement. Submissions are limited to twenty pages of text, excluding the cover letter and table of contents, and may include an optional appendix.
Dhhs-Division Of Human Services

POSTED

about 13 hours ago

DEADLINE

in 15 days
View Details
NAICS: 541512
New
SLED
Faculty Information Management System-242-27-0002-AS
Solicitation # 242-27-00002-AS
Christopher Newport University is soliciting proposals for a fully realized, off-the-shelf Faculty Information System (FIS) to manage faculty activity reporting, annual reviews, and the creation of electronic dossiers for promotion and tenure. The selected vendor must provide a hosted solution that powers faculty web profiles and includes a searchable database for research expertise using a customizable taxonomy. Key functional requirements include the ability to produce ad hoc accreditation reports for SACSCOC and AACSB, integration with ORCID, Digital Object Identifiers, ERP systems, and grant databases, and full compatibility across OSX, Windows, and Linux devices. The system must adhere to Section 508 and WCAG 2.1 Level AA accessibility standards, with vendors required to provide a Voluntary Product Accessibility Template. The contract is governed by the laws of the Commonwealth of Virginia and its Purchasing Manual for Institutions of Higher Education. The initial period of performance runs from the date of execution through December 31, 2029, with two optional one-year renewals. Implementation is estimated to go live between June 30 and December 31, 2027. Award selection is based on the best proposal, where pricing is an objective factor but not the sole determinant. Vendors must provide perpetual software licenses and are required to conduct national criminal history background checks for all personnel with system access. Compliance with FERPA, HIPAA, and the Virginia Consumer Data Protection Act is mandatory. Proposals must be submitted via the Euna Procurement portal by October 28, 2026, and must include a Small Business Subcontracting Plan and various certifications regarding conflict of interest and debarment status.
Christopher Newport University

POSTED

about 20 hours ago

DEADLINE

in 27 days
View Details

More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Same awarding agency

NAICS: 541714
New
Federal
Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Solicitation # ARPA-H-SOL-26-164
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals for the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program under solicitation ARPA-H-SOL-26-164. This five-year initiative aims to create a reusable blueprint for future adaptive seamless platform trials through the integration of three technical areas: a Phaseless Design Engine, Continuous Inference, and Agentic Operations. The program is divided into two stages, with Stage I focusing on capability buildout, FDA engagement, and the onboarding of at least three intervention arms over 24 months, followed by a 36-month Stage II dedicated to validation and deployment. A critical go/no-go milestone is obtaining FDA authorization for the platform Master Protocol IND and at least one investigational arm by the end of Stage I. The government intends to make multiple awards via Other Transaction Agreements to proposers offering the most advantageous solutions based on innovation, feasibility, and technical merit at reasonable prices. Eligible entities must possess a Unique Entity Identifier and active SAM registration. Proposals are submitted in a phased approach, beginning with a Solution Summary and potentially progressing to a Solution Pitch package. Performance will be measured by the successful integration of the three technical areas and the achievement of specific program metrics. All work must adhere to ICH E6(R3) Good Clinical Practice and strict regulatory standards to ensure inspection readiness and participant safety.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in about 2 months
View Details
NAICS: 541714
New
Federal
SURPASS Webinar and Proposers' Day Information
Solicitation # ARPA-H-SN-26-164
The Advanced Research Projects Agency for Health (ARPA-H), under the Department of Health and Human Services, has issued Special Notice ARPA-H-SN-26-164 regarding the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program. This initiative aims to modernize clinical research by transforming drug and biologics development into a continuous learning system, with the goal of reducing development timelines from over ten years to fewer than four. The program focuses on creating disease-specific multi-arm platforms that integrate AI-powered operational infrastructure, in silico modeling, and advanced adaptive designs to enable a seamless transition from first-in-patient evaluation to confirmatory assessment. Key outputs include a reusable blueprint for future trials, simulation-based design tools, and continuous inference and adaptation approaches, all aligning with the goals of HHS Operation TrialBlazer. This specific notice serves as an informational announcement and does not constitute a formal solicitation for proposals. It invites interested parties to an informational webinar on October 15, 2026, and a two-day Proposers Day on November 6 and 9, 2026. Potential participants may optionally submit teaming profiles, lightning talk slides, and posters to showcase their expertise. Full program details and formal solicitation requirements are located under solicitation ARPA-H-SOL-26-164. All inquiries are directed to the SURPASS team, with Daria Fedyukina serving as the Technical Point of Contact.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 11 days
View Details
NAICS: 541714
New
Federal
ARPA-H Comprehensive Organ System Modeling in Outer Space (COSMOS) Innovative Solutions Opening
Solicitation # ARPA-H-SOL-26-165
The Advanced Research Projects Agency for Health (ARPA-H) is seeking proposals under solicitation ARPA-H-SOL-26-165 for the Comprehensive Organ System Modeling in Outer Space (COSMOS) initiative. This program aims to determine if microgravity in Low Earth Orbit (LEO) accelerates tissue aging across brain, cardiac, uterine, and kidney tissues compared to terrestrial rates. If the Tissue Aging Rate in Space (TARIS) is found to significantly exceed the Tissue Aging Rate on Earth (TAROE), the initiative intends to establish a high-throughput, autonomous drug screening platform in LEO to make biomedical research and development more cost-effective and faster than Earth-based methods. The project is structured into two sequential phases: a 27-month Phase I focused on establishing and validating microphysiological systems (MPS) to quantify aging rates, and a 15-month Phase II dedicated to developing age-related pathology models for pro-regenerative drug testing. Key requirements include the use of MPS or organoids for at least 75 percent of experimental samples, the creation of LEO twin experiments, and the establishment of a contractual partnership with at least one Fortune 100 biopharmaceutical company. The program schedule spans FY27 through FY30 and includes two planned space launches in months 39 and 41. Awards will be granted via multiple Other Transaction (OT) Agreements to the most advantageous proposers, including universities, non-profits, and businesses. Evaluation is based primarily on the innovation and feasibility of the technical approach, the potential to transform biomedicine, and the team's expertise in managing costs and schedules. Proposers must adhere to strict administrative requirements, including the BIOSECURE Act, NIH Genomic Data Sharing policies, and specific research security and cybersecurity disclosures. Full proposals are due by October 7, 2026.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

7 days ago

DEADLINE

in 6 days
View Details
NAICS: 541714
New
Federal
ARPA-H Emerging Health Innovators (EHI) Initiative
Solicitation # ARPA-H-SOL-26-150
The Advanced Research Projects Agency for Health (ARPA-H) Emerging Health Innovators (EHI) initiative, solicitation ARPA-H-SOL-26-150, is a mentorship program designed to identify and engage early-career investigators for cutting-edge biomedical, health, and community-engaged research. Eligible principal investigators must be within eight years of completing their first terminal degree. The program focuses on 16 specific topic areas and utilizes a two-step submission process, beginning with an anonymized solution summary due October 30, 2026, followed by full proposals due February 10, 2027. Awards are issued as Other Transaction (OT) agreements with a tentative start date of June 30, 2027. Each award has a total value not to exceed 1,050,000 dollars over a three-year period, consisting of a two-year base period capped at 700,000 dollars and an optional third year capped at 350,000 dollars. Funding is structured around a fixed-price milestone payment schedule, with 12 total quarterly milestones and payments processed through the Payment Management Services (PMS) system. Performance is monitored via monthly one-hour virtual reviews with the ARPA-H program team. Evaluation is based on technical merit, innovativeness, feasibility, and alignment with the ARPA-H mission, with a strong emphasis on risk mitigation and the potential to impact national health research.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

7 days ago

DEADLINE

in 4 months
View Details
NAICS: 541714
Federal
UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO)
Solicitation # ARPA-H-SOL-26-162
The Advanced Research Projects Agency for Health (ARPA-H) has issued Innovative Solutions Opening (ISO) ARPA-H-SOL-26-162 for the UNifying Imaging with QUantum Entanglement (UNIQUE) program. This 18-month, two-phase initiative seeks to develop a new biomedical imaging paradigm by integrating anatomical, functional, and molecular data with quantum-derived observables and entangled 511 keV photon pairs. The scope is divided into two technical areas: TA1, which focuses on the physical systems required to generate and measure quantum observables in biomedical settings, and TA2, which focuses on the computational foundation, including AI-driven reconstruction and multimodal data fusion. ARPA-H anticipates awarding multiple Other Transaction (OT) Agreements to eligible entities, including universities, non-profit organizations, and businesses. For-profit organizations that exceed the NAICS 541714 SBA size standard of 1,000 employees are required to provide a meaningful cost share. The application process follows a two-stage submission cycle, with Solution Summaries due by late October 2026 and Full Proposals due by December 15, 2026, with a final response deadline of December 16, 2026. Full proposals must consist of three volumes covering technical and management plans, cost proposals, and administrative requirements. Evaluation is based on the innovation and feasibility of the technical approach, the expertise of the personnel, the potential to transform biomedicine, and cost reasonableness. Key requirements include compliance with HHS regulations on human stem cells, adherence to cybersecurity standards, and restrictions on gain-of-function research and funding for foreign entities in countries of concern. Awardees will be expected to provide monthly status reports and participate in semi-annual in-person PI review meetings.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

8 days ago

DEADLINE

in 3 months
View Details
NAICS: 541714
Federal
UNifying Imaging with QUantum Entanglement (UNIQUE) Proposers' Day
Solicitation # ARPA-H-SN-26-162
The Advanced Research Projects Agency for Health (ARPA-H), through its Health Science Futures Office, has issued Special Notice ARPA-H-SN-26-162 to announce the UNifying Imaging with QUantum Entanglement (UNIQUE) program. This initiative aims to establish a new biomedical imaging paradigm by utilizing quantum-derived observables, specifically entangled or quantum-correlated 511 keV photon pairs, to reveal disease biology that is currently invisible to existing imaging technologies. The program is divided into two technical areas: an Imaging Core focused on physical systems and quantum-aware detectors, and a second area focused on AI-driven reconstruction and fusion methods to integrate anatomical, functional, molecular, and quantum-derived information. To support this effort, a hybrid Proposers Day is scheduled for October 16, 2026, at 8:30am ET, held at the Executive Conference Center in Arlington, Virginia. This event is designed to provide technical details, promote teaming, and alert the scientific community to an upcoming Innovative Solutions Opening (ISO) that was scheduled for release by September 18, 2026. Interested parties are encouraged to use the provided Lightning Talk Template to showcase their capabilities and teaming goals. While this notice provides program goals and technical direction, it is issued for information and planning purposes and does not constitute a formal solicitation for proposals. The primary point of contact for the program is Program Manager Wilfred Ngwa.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

8 days ago

DEADLINE

in 13 days
View Details
NAICS: 541715
Federal
Restorative and health-Enhancing Sleep Time (REST)
Solicitation # ARPA-H-SOL-26-159
The Advanced Research Projects Agency for Health (ARPA-H) Proactive Health Office has issued solicitation ARPA-H-SOL-26-159 for the Restorative and health-Enhancing Sleep Time (REST) program. This initiative aims to transform the measurement and treatment of poor sleep, specifically insomnia, by developing objective, home-based, closed-loop technologies. The program focuses on detecting and responding to sleep microstructures in real time to improve long-term health outcomes, moving away from traditional macrostructure measures like sleep duration. The scope is divided into two technical areas: Measure and Diagnose (TA1), which focuses on in-home diagnostic systems using objective physiological signals, and Control and Treat (TA2), which focuses on noninvasive, adaptive intervention systems. The program is structured as a 66-month effort spanning three phases: proving the core technical thesis, demonstrating a proof-of-concept, and achieving clinical translation and commercialization. Awards will be granted via Other Transaction (OT) instruments, with payments tied to a quarterly milestone schedule. Evaluation is based on scientific merit, feasibility, innovation, and proposer capabilities, with specific success metrics tied to Polysomnography (PSG) fidelity and diagnostic accuracy. Proposers must submit a Solution Summary by August 12, 2026, and selected candidates will proceed to a full proposal process involving a technical pitch and detailed documentation. The final proposal deadline is October 13, 2026. Requirements include active SAM.gov registration, Institutional Review Board (IRB) approval for human subjects research, and a comprehensive FDA regulatory strategy.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

11 days ago

DEADLINE

in 12 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS